Apremilast in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Pilot Study

LUTS: Lower Urinary Tract Symptoms

Volumn 4, Issue 3, 2012, Pages 140-143

  Mclennan, Gregory P ^a   Khourdaji, Iyad ^a   Killinger, Kim A ^a   Boura, Judith A ^a   Peters, Kenneth M ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Apremilast; Chronic prostatitis chronic pelvic pain syndrome; Pelvic pain; Prostatitis; Treatment

Indexed keywords

APREMILAST;

ADULT; ANALGESIA; ARTICLE; CHRONIC PROSTATITIS; CHRONIC PROSTATITIS SYMPTOM INDEX; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DEFECATION URGENCY; DIARRHEA; DIZZINESS; DRUG DOSE TITRATION; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXPLORATORY RESEARCH; FLUSHING; GLOBAL RESPONSE ASSESSMENT; HUMAN; LEG PAIN; LEG ULCER; MALE; MOUTH ULCER; NAUSEA; NEURALGIA; OPEN STUDY; ORAL BLISTER; OUTCOME ASSESSMENT; PATIENT INFORMATION; PELVIS PAIN SYNDROME; PHYSICAL HEALTH RELATED QUALITY OF LIFE SUBSCALE; PILOT STUDY; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SEXUAL INTERCOURSE; SHORT FORM 12; SIDE EFFECT; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE; URINE INCONTINENCE; VISUAL ANALOG SCALE;

EID: 84866042994     PISSN: 17575664     EISSN: 17575672     Source Type: Journal    
DOI: 10.1111/j.1757-5672.2012.00150.x     Document Type: Article

References (15)

1. Anothaisintawee T, Attia J, Nickel JC et al. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA 2011; 205: 78-86.
2. Schaeffer AJ. Epidemiology and evaluation of chronic pelvic pain syndrome in men. Int J Antimicrobial Agents 2008; 31: 108-11.
3. Litwin MS, McNaughton-Collins M, Fowler FJ Jr et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. J Urol 2008; 162: 369-75.
4. Nickel JC, Roehrborn GC, O'Leary MP et al. Examination of the relationship between symptoms of prostatitis and histological inflammation: Baseline data from the REDUCE chemoprevention trial. J Urol 2007; 178: 896-901.
5. Nadler RB, Koch EA, Calhoun EA et al. IL-1B and TNF-a in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol 2000; 164: 214-218.
6. Schett G, Sloan VS, Stevens RM et al. Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases. Ther Adv Musculoskel Dis 2010; 2: 271-8.
7. Gottlieb AB, Strober B, Krueger JG et al. An open-label, single arm, pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, Apremilast. Curr Med Res Opin 2008; 24: 1529-38.
8. Schafer PH, Parton A, Ghandi AK et al. Apremilast, a cAMP phosphodiesterase-4 inhibitor; demonstrates anti-inflammatory activity in vitro and in a model of psoriasis. Br J Pharmacol 2010; 159: 842-55.
9. McNaughton Collins M, Fowler FJ, Elliot DB et al. Diagnosing and treating chronic prostatitis: do urologists use the four glass test? Urology 2000; 55: 403-7.
10. Celgene Corporation; Summit, New Jersey, USA. PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis. ClinicalTrials.gov [Internet]. Bethesda: National Library of Medicine (US), 2012. [Cited 2 Feb 2012.] Available from URL: http://clinicaltrials.gov/ct2/show/NCT01212770.NLM Identifier:NCT01212770.
11. Shoskes DA, Prots D, Karns J et al. Greater endothelial dysfunction and arterial stiffness in men with chronic prostatitis/chronic pelvic pain syndrome -A possible link to cardiovascular disease. J Urol 2011; 186: 907-10.
12. Nickel JC, Krieger JN, McNaughton-Collins M et al. Alfuzosin and symptoms of chronic prostatitis - chronic pelvic pain syndrome. N Engl J Med 2008; 359: 2663-73.
13. Alexander RB, Propert KJ, Schaeffer AJ et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: A randomized double-blind trial. Ann Intern Med 2004; 141: 581-9.
14. Pontari MA, Ruggieri MR. Mechanisms in chronic prostatitis/chronic pelvic pain syndrome. J Urol 2004; 172: 839-45.
15. Propert KJ, Mayer RD, Wang Y et al. Responsiveness of symptom scales for interstitial cystitis. Urology 2006; 67: 55-9.